Kura Oncology, Inc. (KURA)
NASDAQ · Healthcare
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $961.43M
- P/E ratio
- —
- EPS
- —
- Volume
- 799,313
- 52-week high
- —
- 52-week low
- —
- Open
- $11.01
- Day high
- $11.16
- Day low
- $10.67
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | $67.48M | -$278.67M | -$3.18 |
| 2024 | $53.88M | -$173.98M | -$2.02 |
| 2023 | $0 | -$152.63M | -$2.08 |
| 2022 | — | -$135.84M | -$2.03 |
| 2021 | — | -$130.47M | -$1.97 |
About Kura Oncology, Inc.
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company’s first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications; and KO-7246, a next-generation menin inhibitor, for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in combination with other therapies in solid tumors. The company is headquartered in San Diego, California.
- CEO
- Troy Wilson
- Employees
- 260
- Country
- US
- IPO date
- Sep 16, 2015
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is Kura Oncology, Inc.'s stock price today?
- KURA is trading at $10.68 as of Jul 20, 2026.
- What is Kura Oncology, Inc.'s market cap?
- Kura Oncology, Inc. (KURA) has a market capitalization of $961.43M.
- Does Kura Oncology, Inc. pay a dividend?
- Kura Oncology, Inc. did not pay a dividend in its most recent reported fiscal year.
- What sector is Kura Oncology, Inc. in?
- Kura Oncology, Inc. operates in the Healthcare sector.